Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101
1018528-68-1
890092-07-6 | 2-(4-Acetylpiperazine-1-carbonyl)benzoic acid | AA019OW1 | MFCD05862406
376618-23-4 | 2-(3,4-Difluorobenzoyl)benzoic acid | AA019P2Y | MFCD01013744
55829-49-7 | (4-Methoxyphenyl)(piperazin-1-yl)acetonitrile | AA019P9A | MFCD08271828
929973-96-6 | 1-(Chloroacetyl)-2-methylindoline-5-sulfonamide | AA019PFT | MFCD09040375
1170280-76-8 | 3-Phenylimidazo[1,5-a]pyrazin-1-ol hydrochloride | AA019PNE | MFCD08457591
68502-16-9 | 4-(5-Formyl-2-furyl)benzamide | AA019PW2 | MFCD03925028
548763-38-8 | 1H-Imidazolium, 1-methyl-3-[(3-methyl-1-piperidinyl)carbonyl]-, iodide | AA019QOP | MFCD11099751
1087798-37-5 | 2,2,2-trifluoroethyl N-(3,5-difluorophenyl)carbamate | AA019QSQ | MFCD11099874
1251924-21-6 | 4H,5H,6H,7H-thieno[3,2-c]pyridine-4-carboxylic acid hydrochloride | AA019R6P | MFCD15209729
35509-60-5 | 2,3-Dichloro-4-methoxybenzene-1-sulfonyl chloride | AA019ROY | MFCD11133907
1820648-87-0
1286754-14-0
1553621-50-3
77469-50-2
2070014-94-5
289039-40-3
Journal: Bioorganic & medicinal chemistry letters20101101